Kiora Pharmaceuticals, Inc. (KPRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.16M | -2.18M | -1.27M | -3.8M | -2.7M | -2.25M | 920.06K | -3.73M | 13.62M | -2.58M | -2.52M | -1.38M | -3.07M | -2.13M | -2.97M | -2.5M | -2.83M | -3.2M | -2.27M | -2.92M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | 85.16% | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -16.9% | 3.19% | -238.37% | -1.87% | -119.85% | 12.74% | 136.49% | -169.58% | 543.87% | -21.25% | 15.05% | 44.58% | -8.37% | 33.42% | -30.73% | 14.29% | -10.21% | -87.07% | -30.44% | -98.73% |
| Net Income | -2.42M | -6.52M | 26.81K | -2.15M | -2.19M | -4.22M | -3.41M | -2.22M | 13.45M | -2.27M | -5.76M | -2.61M | -1.87M | -2.5M | -5.12M | -2.4M | -3.57M | -5.75M | -3.03M | -2.54M |
| Depreciation & Amortization | 41.98K | 29.8K | 38.23K | 3.42K | 318 | 5.91K | 2.1K | 17.88K | 4.87K | 7.93K | 42.38K | 22.48K | 10.08K | 10.29K | 10.27K | 10.28K | 10.77K | 59.5K | 11.06K | 12.6K |
| Stock-Based Compensation | 0 | 234.45K | 0 | 262.77K | 148.62K | 160.18K | 171.18K | 0 | 175.44K | 0 | 0 | 171.79K | 135.94K | 0 | 130.15K | 71.25K | 215.92K | 0 | 149.47K | 262.89K |
| Deferred Taxes | 0 | -388.54K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 90.32K | 0 | 0 | 0 | -113.01K | 0 | 0 | 0 | -192.6K | 0 | 0 |
| Other Non-Cash Items | 278.4K | 4.81M | -1.43M | 155.39K | 270.53K | -298.32K | 861.79K | 198.15K | -851 | 195.85K | 3.68M | 177.84K | 241.7K | 2.22K | 1.79M | 69.08K | 280.78K | 3.47M | 115.13K | -157.58K |
| Working Capital Changes | -1.06M | -354.15K | 87.03K | -2.07M | -930.68K | 2.1M | 3.3M | -1.73M | -7.81K | -606.84K | -483.12K | 856.78K | -1.59M | 469.95K | 222.16K | -248.75K | 225.15K | -778.13K | 489.06K | -490.47K |
| Change in Receivables | -257.13K | -648.33K | 446.83K | -1.03M | -1.18M | -33.41K | 2.72M | -1.64M | -10.82K | -529.11K | -575.17K | 888.47K | -332.29K | 301.37K | -1.11M | -34.55K | -33.5K | -106.1K | -112.45K | -162.94K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -303.03K | 655.91K | -40.56K | -662.05K | 1.17M | -224.86K | 384.56K | -58.55K | 124.97K | 40.63K | 15.01K | -508.04K | -355.63K | 147.31K | -6.29K | 499.8K | 141.64K | -300.79K | 132.57K | -165.03K |
| Cash from Investing | 5.4M | 5.35M | 5.74M | 664.17K | 2.67M | 482.68K | -1.92M | -21.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.38K | -93.16K | 0 | -5.75K |
| Capital Expenditures | -5.02K | -78.16K | -431 | -32.2K | 0 | 45.03K | 0 | -51.29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.75K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -93.16K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.38K | 0 | 0 | 0 |
| Cash from Financing | -842 | 296 | 0 | 265.36K | 0 | 0 | 0 | 250.52K | 15.25M | -486.42K | 0 | 5.94M | 513.17K | 3.24M | 5.38M | 0 | 0 | 65.91K | 9.76M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 278.19K | 0 | 0 |
| Equity Issued (Net) | 170 | 296 | 0 | 265.36K | 0 | 0 | 0 | 250.52K | 13.81M | 8.58K | -813.32K | 6.75M | 214.68K | 3.24M | 5.88M | 0 | 0 | 0 | 9.76M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.19M | -1.19M | 0 | 0 | 0 | -84.28K | -15.63K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.01K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.44M | -495K | 813.32K | -813.32K | 298.5K | 0 | -505.02K | 0 | 0 | -212.28K | 0 | 0 |
| Net Change in Cash | 2.26M | 3.19M | 4.48M | -2.74M | -21.27K | -1.85M | -938.03K | -24.7M | 28.82M | -2.95M | -2.55M | 4.53M | -2.58M | 1.16M | 2.37M | -2.64M | -2.79M | -3.25M | 7.44M | -2.95M |
| Free Cash Flow | -3.17M | -2.26M | -1.27M | -3.84M | -2.7M | -2.21M | 920.06K | -3.78M | 13.62M | -2.58M | -2.52M | -1.38M | -3.07M | -2.13M | -2.97M | -2.5M | -2.83M | -3.2M | -2.27M | -2.92M |
| FCF Margin % | - | - | - | - | - | - | - | - | 85.16% | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -17.09% | -2.32% | -238.42% | -1.34% | -119.85% | 14.49% | 136.49% | -173.28% | 543.87% | -21.25% | 15.05% | 44.58% | -8.37% | 33.42% | -30.73% | 14.46% | -7.77% | -84.9% | -30.44% | -99.12% |
| FCF per Share | -0.76 | -0.55 | -0.29 | -0.96 | -0.64 | -0.74 | 0.22 | -0.91 | 0.39 | -0.33 | -0.35 | -0.42 | -1.65 | -1.19 | -3.50 | -7.65 | -8.68 | -12.46 | -8.48 | -15.65 |
| FCF Conversion (FCF/Net Income) | 1.31x | 0.33x | -47.49x | 1.77x | 1.23x | 0.53x | -0.27x | 1.68x | 1.01x | 1.14x | 0.44x | 0.53x | 1.64x | 0.85x | 0.58x | 1.04x | 0.79x | 0.56x | 0.75x | 1.15x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |